Osteoarthritis Trial, Recruiting NCT06054633 Sponsor: Xiangya Hospital of Central South University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06054633
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 40 and 80 years old
  • People who have been diagnosed with knee osteoarthritis according to recognised clinical guidelines
  • People who have had knee pain for 3 months or longer, with pain rated at a moderate-to-high level on a standard osteoarthritis pain scale
  • People whose knee X-rays show a moderate level of joint damage (a specific grading scale score of 2 or 3)
  • People who are willing and able to sign a written consent form

Who may not be able to join:

  • People who have taken anti-inflammatory or pain-relief medicines (such as ibuprofen or similar drugs) in the past two weeks
  • People who have had a steroid injection in the affected knee in the past three months, or a joint fluid (hyaluronic acid) injection in the past six months
  • People who have had surgery on the affected knee in the past 12 months
  • People who have already had a knee replacement in the affected knee, or who are planning to have one within the next three months
  • People who have had a severe injury to the affected knee
  • People whose knee pain is caused by conditions other than osteoarthritis, such as an inflammatory disease, an autoimmune condition, or cancer
  • People with abnormal liver or kidney function test results above a certain level (confirm with trial site)
  • People with serious breathing or lung conditions
  • People with a history of heart disease or heart failure
  • People with high blood pressure or diabetes that is not well controlled
  • People who have been diagnosed with cancer
  • People who are pregnant, planning to become pregnant, or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guanghua Lei, MD, PhD, Xiangya Hospital of Central South University

Phone: 86-18692267896

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xiangya Hospital of Central South University
Registry
ClinicalTrials.gov
Start date
20 March 2024
Est. completion
30 September 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov